EXTH-11. TREATMENT WITH DELTA-24-RGDOX OF SUBCUTANEOUS TUMORS RESULTS IN ABSCOPAL EFFECT ERADICATING INTRACRANIAL MELANOMAS

Immune checkpoint blockade has revolutionized cancer therapy; however the therapeutic benefit is limited to only a subset of patients with immunogenic (“hot”) tumors and is compromised by immune-related adverse events. We have reported the efficacy of oncolytic adenovirus Delta-24-RGDOX (DNX-2440) i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Jiang, Hong, Ho Shin, Dong, Nguyen, Teresa, Alonso, Marta M, Lang, Frederick, Gomez-Manzano, Candelaria, Fueyo, Juan
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Experimental Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847857/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.345
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares